| Literature DB >> 29299913 |
Bilal Demir1, Michael M Lemberger2, Maria Panagiotopoulou3, Paulina X Medina Rangel3, Suna Timur1,4, Thomas Hirsch2, Bernadette Tse Sum Bui3, Joachim Wegener2, Karsten Haupt3.
Abstract
War against cancer constantly requires new affinity tools to selectively detect, localize, and quantify biomarkers for diagnosis or prognosis. Herein, carbon nanodots (CDs), an emerging class of fluorescent nanomaterials, coupled with molecularly imprinted polymers (MIPs), are employed as a biocompatible optical imaging tool for probing cancer biomarkers. First, N-doped CDs were prepared by hydrothermal synthesis using starch as carbon source and l-tryptophan as nitrogen atom provider to achieve a high quantum yield of 25.1 ± 2%. The CDs have a typical size of ∼3.2 nm and produce an intense fluorescence at 450 nm upon excitation with UV light. A MIP shell for specific recognition of glucuronic acid (GlcA) was then synthesized around the CDs, using the emission of the CDs as an internal light source for photopolymerization. GlcA is a substructure (epitope) of hyaluronan, a biomarker for certain cancers. The biotargeting and bioimaging of hyaluronan on fixated human cervical cancer cells using CD core-MIP shell nanocomposites is demonstrated. Human keratinocytes were used as noncancerous reference cells and indeed, less staining was observed by the CD-MIP.Entities:
Keywords: cancer cell imaging; carbon dot; glucuronic acid; hyaluronan; internal light source; molecularly imprinted polymer; synthetic antibody
Mesh:
Substances:
Year: 2018 PMID: 29299913 DOI: 10.1021/acsami.7b16225
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229